Metraipolis › archive › dc_ddda3194a99d

Efficacy and Safety of Vildagliptin Versus Other Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in the Management of Type 2 Diabetes Mellitus: A Systematic Review… — Europe PMC PMID:40901275

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40901275
DOI
10.7759/cureus.91432
License (as archived)
solo-consultazione
Archived
2026-11-10T04:59:14.552Z
SHA-256 of the archived text
805ff83b7fa7b860459472d7dbfa032c038a865256f6d04f5a9c096fb282863c
Stable URL of this page
https://metraipolis.com/documento/dc_ddda3194a99d

How to cite

Efficacy and Safety of Vildagliptin Versus Other Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in the Management of Type 2 Diabetes Mellitus: A Systematic Review… — Europe PMC PMID:40901275 — Europe PMC (en), https://europepmc.org/article/MED/40901275 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ddda3194a99d (Metraipolis archive dc_ddda3194a99d, sha256 805ff83b7fa7b860459472d7dbfa032c038a865256f6d04f5a9c096fb282863c)
BibTeX
@misc{dcddda3194a99d,
  title = {Efficacy and Safety of Vildagliptin Versus Other Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in the Management of Type 2 Diabetes Mellitus: A Systematic Review… — Europe PMC PMID:40901275},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40901275},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ddda3194a99d; sha256 805ff83b7fa7b860459472d7dbfa032c038a865256f6d04f5a9c096fb282863c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40901275. Agents can read the archived copy with the MCP tool read_document.